P-ANCA-positive Wegener's granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: Case report and review of literature

Neuropathology

Volumn 20, Issue 1, 2000, Pages 23-30

  Nagashima, Toshiko ^a   Maguchi, Shiro ^a   Terayama, Yoshihiko ^a   Horimoto, Midori ^a   Nemoto, Masashi ^a   Nunomura, Mitsuru ^a   Mori, Masamitsu ^a   Seki, Takashi ^b   Matsukawa, Satoru ^c   Itoh, Tomoo ^c   Nagashima, Kazuo ^c,d  

^a Teine Keijinki Hospital   (Japan)

^b Nakamura Memorial Hospital   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Hypertrophic pachymeningitis; Multiple cranial neuropathies; p ANCA; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID;

ADULT; ARTICLE; AUTOPSY; BIOPSY; BLINDNESS; CASE REPORT; CAVERNOUS SINUS; CERVICAL SPINAL CORD; CLINICAL FEATURE; CRANIAL NEUROPATHY; DURA MATER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISCLERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MENINGITIS; NEUROLOGIC DISEASE; ORBIT; PARANASAL SINUS; PARAPLEGIA; PRIORITY JOURNAL; SPINAL CORD TUMOR; STEROID THERAPY; THORACIC SPINAL CORD; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CEREBRAL ANGIOGRAPHY; CRANIAL NERVE DISEASES; DURA MATER; FATAL OUTCOME; FEMALE; HUMANS; HYPERTROPHY; MAGNETIC RESONANCE IMAGING; MENINGITIS; MIDDLE AGED; WEGENER GRANULOMATOSIS;

EID: 6744251980     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00282.x     Document Type: Article

References (46)

1. Wegener F. Über eine eigentartige rhinogene Granulomatose mit besonder Beteiligung des Arterien-systems und der Nieren (in German). Beitr Pathol Anat Allg Pathol 1939; 102: 36-68.
2. Duna GF, Galperin C, Hoffman GS. Wegener's granulomatosis. Rheum Dis Clin North Am 1995; 21: 949-986.
3. van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; I (8426): 425-429.
4. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15.
5. Specks U, Homburger HA. Anti-neutrophil cytoplasmic antibodies. Mayo Clin Proc 1994; 69: 1197-1198.
6. Drachman DD. Neurological complications of Wegener's granulomatosis. Arch Neurol 1963; 8: 145-155.
7. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
8. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: An analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33: 4-9.
9. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992; 116: 488-498.
10. Weinberger LM, Cohen ML, Remler BF, Naheedy MH, Leigh RJ. Intracranial Wegener's granulomatosis. Neurology 1993; 43: 1831-1834.
11. Newman NJ, Slamovits TL, Friedland S, Wilson WB. Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis. Am J Ophthalmol 1995; 120: 613-621.
12. Hern JD, Hollis LJ, Mochloulis G, Montgomery PQ, Tolley NS. Early diagnosis of Wegener's granulomatosis presenting with facial nerve palsy. J Laryngol Otol 1996; 110: 459-461.
13. Jinnah HA, Dixon A, Brat DJ, Hellmann DB. Chronic meningitis with cranial neuropathies in Wegener's granulomatosis. Case report and review of the literature. Arthritis Rheum 1997; 40: 573-577.
14. Maguchi S, Takizawa M, Miyatake Y, Nakamuru Y, Fukuda S, Inuyama Y. Antineutrophil cytoplasmic antibody (C-ANCA) levels in relation to the treatment of Wegener's granulomatosis (in Japanese). Nippon Jibiinkoka Gakkai Kaiho 1995; 98: 974-983.
15. Feringa ER, Weatherbee L. Hypertrophic granulomatous cranial pachymeningitis causing progressive blindness in a chronic dialysis patient. J Neurol Neurosurg Psychiatry 1975; 38: 1170-1176.
16. Eto F, Shimada Y, Endo H, Mozai T. Wegener's granulomatosis with marked pachymeningitis: An autopsy study. Rinsho Shinkeigaku 1976; 16: 326-332.
17. Gorell JM, Palutke WA, Chason JL. Candida pachymeningitis with multiple cranial nerve pareses. Arch Neurol 1979; 36: 719-720.
18. Oonishi T, Ishiko T, Arai M, Kase M, Matsushita M. Pachymeningitis cervicalis hypertrophica. Acta Pathol Jpn 1982; 32: 163-171.
19. Hattori S, Mochio S, Abe M, Sanada S, Nakajima T. An autopsied case of multiple cranial nerve palsies due to chronic hypertrophic pachymeningitis (in Japanese). Shinkei Naika 1984; 20: 134-139.
20. Hirabuki N, Marukawa T, Imakita S et al. A case of hypertrophic pachymeningitis (in Japanese). Rinsho Hoshasen 1985; 30: 613-616.
21. Kobayashi N, Kongo K, Kawauchi M, Kobayashi S, Sugita K. Chronic meningitis with marked unilateral tentorial pachymeningitis. Surg Neurol 1985; 23: 529-535.
22. Berger JR, Snodgrass S, Glaser J, Post MJ, Norenberg M, Benedetto P. Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis. Neurology 1989; 39: 1345-1349.
23. Okimura Y, Tanno H, Karasudani H, Suda S, Ono J, Isobe K. A case of hypertrophic cranial pachymeningitis (in Japanese). No Shinkei Geka 1991; 19: 259-262.
24. Ueba T, Nakao S, Kageyama N. Hypertrophic cranial pachymeningitis associated with hydrocephalus: A case report plus a summary of 14 previous cases (in Japanese). Jpn J Neurosurg 1992; 1: 260-264.
25. Masson C, Henin D, Hauw JJ, Rey A, Raverdy P, Masson M. Cranial pachymeningitis of unknown origin: A study of seven cases. Neurology 1993; 43: 1329-1334.
26. Lam BL, Barrett DA, Glaser JS, Schatz NJ, Brown HH. Visual loss from idiopathic intracranial pachymeningitis. Neurology 1994; 44: 694-698.
27. Moore AP, Rolfe EB, Jones EL. Pachymeningitis cranialis hypertrophica. J Neurol Neurosurg Psychiatry 1985; 48: 942-944.
28. Sasaki R, Taniguchi A, Narita Y, Naito Y, Kuzuhara S. A case of optic neuropathy, recurrent transverse myelopathy and hypertrophic pachymeningitis associated with perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) (in Japanese). Rinsho Shinkeigaku 1995; 35: 513-515.
29. Nishikawa M, Sakamoto H, Kishi H et al. A case of rheumatoid factor-positive pachymeningitis (in Japanese). No Shinkei 1996; 48: 735-739.
30. Tanaka M, Suda M, Ishikawa Y, Fujitake J, Fujii H, Tatsuoka Y. Idiopathic hypertrophic cranial pachymeningitis associated with hydrocephalus and myocarditis: Remarkable steriod-induced remission of hypertrophic dura mater. Neurology 1996; 46: 554-556.
31. Girkin CA, Perry JD, Miller NR, Reich SG. Pachymeningitis with multiple cranial neuropathies and unilateral optic neuropathy secondary to Pseudomonas aeruginosa: Case report and review. J Neuroophthalmol 1998; 18: 196-200.
32. Kafka SP, Condemi JJ, Marsh DO, Leddy JP. Mononeuritis multiplex and vasculitis. Association with anti-neutrophil cytoplasmic antoantibody. Arch Neurol 1994; 51: 565-568.
33. Oguni E, Watanabe S, Nagata H, Mizusawa H, Shoji S. A case of nonsystemic vasculitic neuropathy with anti-neutrophil cytoplasm antibody (in Japanese). Rihsho Shinkeigaku 1994; 34: 470-473.
34. Sasaki A, Hirato J, Nakazato Y, Tanaka T, Takeuchi H. An autopsy case of P-ANCA-positive microscopic polyangiitis with multiple cerebral hemorrhagic infarction (in Japanese). No Shinkei 1998; 50: 56-60.
35. Shindo K, Nitta K, Nagasaka T, Shiozawa Z. Idiopathic hypertrophic cranial pachymeningitis associated with Homer's syndrome. A case report (in Japanese). Rinsho Shinkeigaku 1997; 37: 300-303.
36. Jennette JC, Falk RJ. Clinical and pathological classification of ANCA-associated vasculitis: What are the controversies? Clin Exp Immunol 1995; 101 (Suppl. 1): 18-22.
37. Mayet WJ, Helmreich-Becker I, Meyer zum Buschenfelde KH. The pathophysiology of anti-neutrophil cytoplasmic antibodies (ANCA) and their clinical relevance. Crit Rev Oncol Hematol 1996; 23: 151-165.
38. Davie DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? BMJ 1982; 285: 606.
39. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: A review. Am J Kidney Dis 1990; 15: 17-29.
40. Edgar JD. The clinical utility of ANCA positivity. Ann Rheum Dis 1996; 55: 494-496.
41. Davenport A, Lock RJ, Wallington TB, Feest TG. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay. QJ Med 1994; 87: 291-299.
42. Fujita H, Hagiwara A, Yamaguchi T, Terada T, Yoshida M. A study of c-ANCA negative Wegener's granulomatosis. Pract Otol 1999; 92: 293-298.
43. Yagyu H, Namshima K, Koshikawa S et al. A case of MPO-ANCA positive Wegener's granulomatosis accompanying acute pulmonary hemorrhage (in Japanese). Jpn J Chest Dis 1996; 55: 1005-1010.
44. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-1998. A 64-year-old man with cranial-nerve palsies and a positive test for antinuclear cytoplasmic antibodies. N Engl J Med 1998; 339: 755-763.
45. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-1999. A 74-year-old woman with hydrocephalus and pleocytosis. N Engl J Med 1999; 340: 945-953.
46. Sugiyama Y, Shimizu M, Hoshi A et al. An old man presenting with fluctuating bilateral multiple cranial nerve palsies and positive test for perinuclear antineutrophil cytoplasmic antibody (in Japanese). No Shinkei 1999; 51: 825-832.